Gastric Neurofibroma: Is It Cancer?

Gastric neurofibroma is a benign tumor that develops in the stomach and is not classified as cancer. However, approximately 10% of these tumors have the potential to undergo malignant transformation if left untreated. This is why early detection and monitoring are crucial for long-term health outcomes.

In its early stages, gastric neurofibroma may not cause noticeable symptoms, making it difficult to detect. Patients often experience no significant discomfort initially. As the tumor grows, however, symptoms such as stomach pain, especially after eating, and a feeling of fullness or bloating may begin to appear.

If the tumor becomes large enough to cause obstruction or severe symptoms, diagnostic procedures such as endoscopy, CT scans, and pathological biopsies are typically recommended to confirm the diagnosis and assess the tumor's nature. These tests are essential in determining whether the tumor remains benign or has started to change malignantly.

Treatment options vary depending on the size and progression of the tumor. Smaller gastric neurofibromas can often be removed or managed through endoscopic procedures, which are less invasive and allow for quicker recovery. However, if the tumor is large or has undergone malignant transformation, surgical intervention may be necessary to fully remove the affected tissue and prevent further complications.

In summary, while gastric neurofibroma is not cancerous by nature, its potential for malignant change highlights the importance of timely diagnosis and appropriate treatment. Paying attention to subtle symptoms and seeking medical advice early can significantly improve patient outcomes.